| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRSP. Recent filings cover 0 purchases and 109 sales. Those positions are worth an estimated $15.5M at current prices.
Our model assigns Kulkarni Samarth a middling insider score of 68/100, based on 37 past trades. Over a 12-month horizon, 58.1% of those trades were profitable, with an average 12-month return of +7.5%.
Kulkarni Samarth's largest disclosed position is in CRSP as Chief Executive Officer, worth about $15.5M. The recent filings there lean toward selling, a net 1,049,894 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,031 | $41.23 | $413,578.13 | -4.9% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 14,435 | $42.70 | $616,348.50 | -7.2% | -1.3% | +12.4% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 18,360 | $55.21 | $1,013,563.80 | -9.7% | -26.0% | +3.1% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 18,568 | $54.21 | $1,006,580.40 | -8.9% | -26.0% | +3.1% | |
| Dec 2, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 15,000 | $55.10 | $826,564.50 | -7.6% | -23.3% | -6.5% | |
| Nov 11, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 30,000 | $55.62 | $1,668,678.36 | -13.2% | -28.2% | +0.6% | |
| Oct 14, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 4,293 | $46.28 | $198,680.04 | -1.9% | -18.8% | +45.1% | |
| Apr 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 19,582 | $59.91 | $1,173,231.52 | -8.6% | -2.1% | -33.7% | |
| Mar 15, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $72.48 | $1,449,628.16 | -8.8% | -10.5% | -42.3% | |
| Mar 12, 2024 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 14,385 | $77.04 | $1,108,263.04 | -6.5% | -20.3% | -42.2% |